광견병 진단을 위한 팬-리사바이러스 실시간 RT-PCR

Executive Industry Relevance

This pan-lyssavirus real-time RT-PCR assay provides a sensitive, specific, and cost-effective method for detecting rabies virus across the Lyssavirus genus, supporting early detection in both human and animal samples. Its closed-tube SYBR Green design minimizes contamination risk and enables high-throughput screening in diagnostic laboratories. The assay’s ability to detect highly divergent lyssaviruses enhances surveillance capabilities and informs public health decision-making for zoonotic disease preparedness.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of viral host range and pathogenesis across divergent lyssavirus species.
• Operational Value: Supports functional validation of antiviral targets by confirming viral presence in preclinical models.

Screening & Assay Development

• Scientific Value: Provides a standardized, quantitative readout for antiviral compound screening against lyssaviruses.
• Operational Value: Facilitates assay reproducibility and scalability due to probe-free SYBR Green chemistry and dissociation curve verification.

Translational & Preclinical Research

• Scientific Value: Enables longitudinal monitoring of viral load in animal models to assess vaccine or therapeutic efficacy.
• Operational Value: Supports GLP-compliant workflows with built-in controls (Beta-Actin, no-template) for data integrity.

Pipeline & Workflow Integration

The assay fits within the antiviral discovery continuum from target validation through lead optimization, offering a reliable endpoint for measuring viral inhibition in lyssavirus-infected systems.

• Discovery Biology: Confirms viral infection status in cell culture or animal models, supporting mechanism-of-action studies.
• Screening: Delivers CT values and melt curves as quantitative outputs for hit confirmation and dose-response profiling.
• Analytics: Generates amplification and dissociation data enabling inter-laboratory comparability and assay standardization.
• Translational Research: Connects in vitro findings to ex vivo clinical sample detection, strengthening translational confidence.
• Enterprise Reuse: Can be deployed across multiple lyssavirus targets, reducing need for species-specific assay development.

Operational & Enterprise Impact

• Scientific Value: Broad-spectrum detection reduces false negatives and improves confidence in target engagement data.
• Operational Value: Closed-tube design and minimal reagent cost increase throughput and lower operational burden.
• Strategic Value: Enables faster go/no-go decisions in antiviral programs by providing early, sensitive viral load metrics.
• Portfolio Impact: Supports risk-adjusted prioritization of candidates with demonstrated cross-genus activity.

Implementation Considerations

• Requires expertise in real-time PCR setup, melt curve analysis, and nucleic acid handling.
• Needs a real-time PCR instrument with SYBR Green and dissociation mode capability.
• Demands strict spatial separation of pre- and post-amplification areas to prevent amplicon contamination.
• May require exogenous internal controls when testing low-host-nucleic-acid samples like saliva or CSF.
• Assay validation should include panel testing against known lyssavirus strains to confirm inclusivity.

Biopharma FAQs